Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique

Size: px
Start display at page:

Download "Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique"

Transcription

1 Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique Michele De Bonis, MD; Elisabetta Lapenna, MD; Giovanni La Canna, MD; Eleonora Ficarra, MD; Marco Pagliaro, MD; Lucia Torracca, MD; Francesco Maisano, MD; Ottavio Alfieri, MD Background The aim of this study was to assess the results of mitral valve (MV) repair in functional mitral regurgitation because of end-stage dilated cardiomyopathy (DCM). Methods and Results Seventy-seven patients with end-stage idiopathic (26 patients) or ischemic (51 patients) DCM underwent MV repair for functional mitral regurgitation (3 to 4 /4 ). Fifty-eight patients (75.3%) were in New York Heart Association class III, and 19 (24.6%) were in IV. In 23 patients (29.8%) with a coaptation depth 1 cm, an isolated undersized annuloplasty was used. In the remaining 54 (70.1%), with a coaptation depth 1 cm, the edge-to-edge technique was associated with the annuloplasty. In most of the cases (88.3%), a complete rigid/semirigid ring was used. Concomitant coronary artery bypass graft was performed in 39 patients (50.6%). Hospital mortality was 3.8% (3 of 77). Actuarial survival was %, and freedom from cardiac events was % at 2.7 years. At a mean follow-up of months (range, 1 month to 5 years) New York Heart Association class improved from to (P ). Mitral repair failure (recurrence of MR 3 /4 ) was documented in 7 patients (9%): 2 in the edge-to-edge (2 of 54, 3.7%) and 5 in the isolated annuloplasty group (5 of 23, 21.7%) (P 0.03). Freedom from repair failure at 1.5 years was % and %, respectively (P 0.04). The absence of the edge-to-edge was the only predictor of repair failure (P 0.03). When residual MR was absent or mild, a reverse left ventricular remodeling was clearly documented. Conclusions In patients with end-stage DCM, MV repair is feasible with low hospital mortality and important symptomatic improvement. The association of the edge-to-edge technique to the undersized annuloplasty can significantly improve the durability of the repair. (Circulation. 2005;112[suppl I]:I-402 I-408.) Key Words: mitral regurgitation edge-to-edge technique dilated cardiomyopathy In ischemic or idiopathic dilated cardiomyopathy (DCM), left ventricular (LV) dysfunction is frequently complicated by functional mitral regurgitation (FMR). Undersized ring annuloplasty has been used for the treatment of FMR, although mitral insufficiency can recur in a significant number of cases. 1 3 The durability of such a procedure seems to be particularly unreliable in patients with mild-to-moderate annular dilatation, severe tethering, and complex jets. 1 2 In these cases, chordal-sparing valve replacement or, alternatively, other reconstructive procedures, including the edgeto-edge technique, have been proposed. 2,4 Previous studies with the edge-to-edge repair for FMR have alternately reported encouraging, 5 satisfactory, 6 or disappointing results. 7 Most of the unfavorable outcomes, however, have been described when the edge-to-edge technique has been used without any concomitant annuloplasty 5 or in association with only a posterior flexible band, 5,7 which could not prevent the progression of annular dilatation in the setting of DCM. In this study, we hypothesized that, in presence of FMR and important leaflet tethering, the association of the edge-toedge technique to the undersized annuloplasty could improve the durability of the repair, provided that a complete ring is used and that the surgical correction is guided by specific echocardiographic information. Methods Study Population The study population consisted of 77 patients with end-stage DCM and severe (4 /4 ) or moderately severe (3 /4 ) mitral regurgitation (MR), refractory to medical therapy, who underwent mitral repair from 1998 to March The etiology of DCM was ischemic in 51 cases (67.2%) and idiopathic in 26 (33.8%). All of the patients had severe LV dysfunction [ejection fraction (EF) 35%] and had been hospitalized 1 to 5 times for congestive heart failure (CHF) in the previous 6 months despite maximal medical therapy. The baseline characteristics are presented in Table 1. Patients with intrinsic mitral valve (MV) disease, unstable angina or recent myocardial infarction ( 6 months), papillary muscle rupture, severe right ventricular dysfunction, multiple organ failure, EF 35%, From the Cardiac Surgery Department, San Raffaele University Hospital, Milan, Italy Correspondence to Dr Michele De Bonis, Cardiac Surgery Department, San Raffaele University Hospital, Via Olgettina 60, Milan, Italy. michele.debonis@hsr.it 2005 American Heart Association, Inc. Circulation is available at DOI: /CIRCULATIONAHA I-402

2 De Bonis et al Mitral Valve Repair in End-Stage Cardiomyopathy I-403 TABLE 1. Preoperative Data Variables N (%) Patients 77 Male/female 56/21 Age, years (range 25 79) Primary DCM 26 (33.8) Ischemic DCM 51 (67.2) NYHA class III 58 (75.3) IV 19 (24.6) Angina 7 (9) Preoperative rhythm Sinus rhythm 62 (80.5) Atrial fibrillation 9 (11.6) Pacemaker 6 (7.7) Admission for CHF (previous 6 months) MR grade Moderately severe (3 ) 24 (31.1) Severe (4 ) 53 (69.9) EF (%) concomitant LV reconstruction, or aortic valve procedures were excluded from the study. Echocardiography All of the patients underwent transthoracic (TTE) followed by transesophageal echocardiography (TEE). The severity of MR was graded as follows: mild, 1 (jet area/left atrial area 10%); moderate, 2 (jet area/left atrial area 10% to 20%); moderately severe, 3 (jet area/left atrial area 20% to 45%); and severe, 4 (jet area/left atrial area 45%). The vena contracta width, at the narrowest portion of the regurgitant jet, the coaptation depth, the tenting area of the MV, and the site of origin of the regurgitant jet were also measured and analyzed. The severity and precise mechanism of MR were confirmed by TEE. Dobutamine stress echocardiography was performed in all of the ischemic patients but 8 (15.6%) in whom atrial fibrillation, sinus tachycardia, or inducible ventricular arrhythmias were present. Dobutamine stress echocardiography was performed as described previously 8 to assess the viability and contractile reserve and to distinguish patients who could benefit from concomitant coronary artery bypass graft (presence of viability) from those who required only MV surgery (absence of viability). Immediately after surgery, TEE was repeated to assess residual MR, transmitral diastolic gradient (from continuous-wave Doppler), and MV area (by direct planimetry). Serial TTEs were then performed at hospital discharge, within 3 months (average, ) and every 6 months after surgery. Echo-Guided Approach and Surgical Technique In MR secondary to DCM, the MV is structurally normal, and the intraoperative inspection does not provide additional information useful to the choice of the surgical technique. The preoperative echocardiographic study, therefore, has literally to be used as a guide for the surgical correction providing detailed information about the degree of annular dilatation (intercommissural/septolateral dimensions), the severity of leaflet tethering (coaptation depth/tenting area), and the number and localization of the regurgitant jets. The strategy adopted in our institution can be simplified as follows: in the presence of annular dilatation and moderate leaflet tethering (coaptation depth 1 cm), an undersized annuloplasty alone, with a complete ring, was used. On the other hand, when the degree of tethering was more pronounced (coaptation depth 1 cm), Figure 1. Flow chart of the echo-guided surgical strategy for correction of FMR in end-stage DCM. an association of the edge-to-edge technique to the undersized annuloplasty was preferred, with the aim to prevent the recurrence of MR and improve the durability of the repair. The edge-to-edge repair was always performed in correspondence with the site of origin of the regurgitant jet: centrally (in case of central jet) or posteromedially (when the regurgitant jet was in correspondence of the posterior commissure) (Figure 1). When more than 1 jet was identified, the edge-to-edge was applied on the largest one, relying on the undersized ring for the resolution of the others. All of the patients, with or without edge-to-edge, received an undersized annuloplasty with a complete ring, rigid or semirigid in most of the cases. An intraaortic balloon pump (IABP) was prophylactically inserted in 60 patients (77.9%) before skin incision. The distribution of those patients with IABP insertion was not different between the 2 groups (P 0.7). Although initially we were using IABP on an asneeded basis after the operation, from December 2000, we decided to adopt a prophylactic IABP in all of the patients with severe LV dysfunction. We used this approach also in nonischemic patients in whom the decreased afterload provided by the IABP can be helpful considering that those failing hearts, immediately after the operation, have to face the afterload mismatch produced by the newly competent repaired MV. Follow-Up All of the patients were examined in the heart failure clinic with physical examination, ECG, and TTE. The events included cardiac death, reoperation, being listed for heart transplantation, endocarditis, and thromboembolisms. Follow-up was 100% complete (mean time, months; range, 1 month to 5 years; median, 14 months). Statistical Analysis All of the data were prospectively entered in a dedicated database and analyzed. Calculations were performed using SPSS version 11.5 (SPSS Inc.) for the Windows (Microsoft Corp.) software package. Continuous data were compared using the Student t test for paired and unpaired data when appropriate. A comparison of categorical variables was performed using 2 and Fisher s exact test. Repeated measurements were compared by repeated-measures ANOVA. The Bonferroni test was used to adjust the observed significance level for the fact that multiple comparisons were made. Survival and freedom from events were analyzed with Kaplan-Meier actuarial methods. The comparison among groups was performed according to the log rank method. Univariate analysis of risk factors was performed with Cox proportional hazards regression. All of the data are presented as mean SD (for actuarial estimates, SE is reported instead). Results Of 77 patients, 23 had a coaptation depth 1 cm and underwent isolated undersized annuloplasty (ring-only group). In the remaining 54 patients, the coaptation depth was 1 cm, and an edge-to-edge was associated with the ring annuloplasty (edge-to-edge group). Preoperative characteris-

3 I-404 Circulation August 30, 2005 TABLE 2. Clinical and Echocardiographic Data in the Ring Only and Edge-to-Edge Groups Variables Undersized Ring Only EE Undersized Ring P Value No. patients EF, % LVEDD, mm LVEDV, ml LVESV, ml SPAP, mm Hg Tenting area, cm Coaptation depth, cm Mitral annulus Intercommissural, mm Septal-lateral, mm Ring no Complex jet, n (%) 4/23 (17.3%) 17/54 (31.4%) 0.2 Associate CABG, n (%) 13/23 (56.5%) 26/54 (48.1%) 0.5 Medical therapies, % ACE inhibitors Blockers Diuretic Spironolactone Digoxin EE indicates edge-to-edge; LVEDD, end-diastolic diameter; LVEDV, end-diastolic volume; LVESV, end-systolic volume; SPAP, systolic pulmonary artery pressure. tics were comparable in the 2 groups, although the mean tenting area and coaptation depth were obviously higher in the edge-to-edge one. All of the patients were receiving heart failure medication at the maximal tolerated dose without significant differences between the 2 groups (Table 2). A single central regurgitant jet was documented in 19 cases (82.7%) in the ring-only group and in 37 cases (68.6%) in the edge-to-edge one (P 0.2). The remaining patients in both groups presented a complex jet (an eccentric jet originating from the medial commissure or a central jet associated with a subcommissural or a commissural one). The prevalence of complex jets was comparable in the 2 groups. The edge-toedge repair was performed centrally in 47 cases (87%) and posteromedially in 7 (13%). All of the patients, with and without edge-to-edge, received an undersized complete ring. The annuloplasty rings were semirigid (Seguin, St. Jude Medical) or rigid (Carpentier Edwards, Classic) in 88.3% of the cases (68 of 77) and flexible (Duran, Medtronic Inc.) in 9 patients (11.7%) (Figure 2). The flexible rings were used exclusively at the beginning of our experience and then abandoned according to the new emerging evidence that more rigid devices should be preferred in the setting of DCM. 9 The dimensions of the mitral annulus and the type of ring did not significantly differ between the 2 groups. Undersizing was initially achieved by using a ring that was 2 sizes smaller than the annular size measured intraoperatively. Intraoperative measurement was thereafter abandoned, and we simply used the smallest ring we could implant without inducing mitral stenosis, this being a number 26 in patients receiving an isolated undersized annuloplasty and a number 28 in those submitted to concomitant edge-to-edge repair. Thus, in patients receiving the edge-to-edge, the mean ring size was significantly higher ( ; range, 26 to 31) than in patients undergoing undersized annuloplasty alone ( ; range, 25 to 30; P 0.01) (Figure 3). Concomitant CABG was performed in 39 of 51 patients (76.4%) with Figure 2. Type of rings.

4 De Bonis et al Mitral Valve Repair in End-Stage Cardiomyopathy I-405 patients (10.3%), bipolar radiofrequency ablation of permanent atrial fibrillation in 9 (11.6%), and cardiac support device (CorCap, ACORN Cardiovascular) implant in 2 (2.5%). Figure 3. Size of rings. ischemic DCM (mean grafts per patient). The target coronary artery was the left anterior descending in 42.5% of the cases, obtuse marginal in 28.7%, posterior descending artery in 20%, and diagonal branches in 8.5%. In the remaining 12 ischemic patients (23.6%), myocardial revascularization was not performed because of unsuitable coronary anatomy (3 patients) or the presence of scar in the target region (9 patients). The distribution of those 12 patients was not significantly different between the 2 groups (P 0.4). Other associated procedures were tricuspid valve repair in 8 TABLE 3. Postoperative Complications Complication No. Percent Low output syndrome 8 (10.3%) Acute renal failure 7 (9.0%) Sepsis 5 (6.4%) Respiratory failure 4 (5.1%) Ventricular arrhythmias 2 (2.5%) TIA 2 (2.5%) Reexploration for bleeding 1 (1.2%) Ictus 1 (1.2%) Median ITU stay, days 5 Median hospital stay, 12 days TIA indicates transitory ischemic attack. TABLE 4. Recurrence of MR at Follow-Up Clinical Outcome Postoperative complications are reported in Table 3. Three patients died within 30 days (3 of 77, 3.8%). Hospital mortality was 4.3% (1 of 23) in the ring-only group and 3.7% (2 of 54) in the edge-to-edge one (P value was not significant; low cardiac output in 2 patients, ventricular arrhythmia in 1). Three more patients (3.8%) died during the follow-up: 1 of pneumonia 6 months postoperatively and 2 of sudden death 3 and 7 months after surgery. The overall actuarial survival was % at 2.7 years ( % in the ring-only group and % in the edge-to-edge group; P 0.9). One patient was reoperated 12 months after an undersized annuloplasty with a 27-mm flexible ring for recurrence of severe MR. One more patient, with 2 recurrent MR at 1 year, was listed for heart transplantation because of persistence of CHF symptoms. Freedom from cardiac events (cardiac death, reoperation, being listed for heart transplantation, endocarditis, and thromboembolisms) was 81.8% 7.96%. New York Heart Association (NYHA) class improved from a preoperative mean of to (P ) with all of the surviving patients but 3 being in class I or II and no significant difference between the 2 groups. Echocardiography At hospital discharge, TTE showed mild MR in 29 (37.6%) patients and no MR in 48 (62.3%). On average, the patients had grade MR, a mean MV area of cm 2 (range, 1.9 to 3.4 cm 2 ) and a mean transmitral diastolic gradient of mm Hg. No significant differences were found between the 2 groups. The first follow-up TTE ( 3 months after surgery) showed similar results. At the last echocardiogram (mean, 1.5 years after surgery), MV area (mean, cm 2 ) and transmitral diastolic gradient (mean, mm Hg) had remained unchanged, whereas MR grade had increased to (P compared with predischarge). In particular, 79.2% of the patients had no or mild MR, and 11.6% showed moderate (2 ) mitral insufficiency (Table 4). Recurrence of 3 to 4 MR occurred in 7 patients (9%): 5 in the ring-only group (5 of 23, 21.7%) because of reappearance of bileaflet tethering and 2 in the edge-to-edge group (2 of 54, 3.7%; P 0.02). In those last 2 patients, a posteromedial edge-to-edge had been performed, and its failure was likely related to insufficient extension of the suture with the reappearance of a commissural regurgitant jet. All of those 7 patients developed MV repair failure within the first postoperative year. A reoperation was performed in 1 of them. The other 6 are currently closely followed-up, as Variables Overall Undersized Ring Only EE Undersized Ring P Value MR 0 1 n (%) 61/77 (79.2%) 15/23 (65.2%) 46/54 (85.2%) MR 2 n (%) 9/77 (11.6%) 3/23 (13%) 6/54 (11.1%) 0.5 MR 3 n (%) 7/77 (9%) 5/23 (21.7%) 2/54 (3.7%) 0.02

5 I-406 Circulation August 30, 2005 TABLE 5. Univariate Analysis of Risk Factors for MV Repair Failure (Recurrence of MR >3 ) Variables Hazard Ratio 95% CI P Value Age Ischemic etiology Previous AMI EF SPAP LVEDD LVEDV LVESV Tenting area Coaptation depth Complex jet Absence of edge-to-edge Ring no Ring type Associate CABG SPAP indicates systolic pulmonary artery pressure; LVEDD, end-diastolic diameter; LVEDV, end-diastolic volume; LVESV, end-systolic volume. they are still in functional class II. Univariate analysis identified the absence of the edge-to-edge as the only predictor of recurrence of MR of grade 3 to 4 (hazard ratio, 4.7; P 0.03). No other risk factor for MV repair failure reached statistical significance or even a probability value 0.10, and, therefore, a multivariable analysis was not performed (Table 5). The ring size was reduced over the duration of the trial, but this had no impact on the mitral repair failure rates. The freedom from recurrence of 3 or 4 MR at 1.5 years was % in the edge-to-edge group and % in the isolated undersized annuloplasty group (P 0.04) (Figure 4). Echocardiographic changes in LV dimensions and function were assessed in patients who had 2 TTE follow-ups. Patients submitted to radiofrequency ablation of atrial fibrillation or cardiac support device implantation and those with recurrence of MR 2 were excluded from the analysis, because all of these conditions would have been confounding factors in the LV remodeling evaluation. Using the criteria described above, 28 patients (20 ischemic and 8 idiopathic) were available for the purpose of this analysis. Four of them were in the ring-only and 24 were in the edge-to-edge group. The mean LV end-diastolic diameter, end-diastolic volume, and end-systolic volume significantly decreased from baseline to early follow-up, remaining stable from early to late postoperative stage (Figure 5). A significant improvement of the EF was documented only in the ischemic DCM patients who received a mean of grafts. In the 8 patients with idiopathic DCM, on the other hand, we observed a significant decrease in the LV dimensions without changes of the EF (from % to %; P 0.22). The same analysis performed in 5 of the 7 patients with 3 to 4 recurrent MR (1 excluded for CorCap implantation and 1 for having had only 1 TTE follow-up), showed that LV dimensions and function had remained comparable with the preoperative values. Insufficient data were available for the patients with moderate (2 ) recurrent MR. Finally, differences in the remodeling pattern between ring-only and edge-to-edge patients could not be assessed for the small number of suitable cases in the isolated undersized annuloplasty group. Discussion The main finding of this study is that the association of the edge-to-edge repair to a complete-ring undersized annuloplasty significantly increases the durability of mitral repair in Figure 4. Freedom from recurrence of MR of grade 3 to 4 in the edge-toedge and in the ring-only groups.

6 De Bonis et al Mitral Valve Repair in End-Stage Cardiomyopathy I-407 Figure 5. Changes in LV end-diastolic volume (LVEDV) (a), end-systolic volume (LVESV) (b), end-diastolic diameter (LVEDD) (c), and EF (d) at preoperative, early postoperative, and late postoperative stages (mean SEM). FMR because of end-stage DCM. This technique restores leaflet coaptation also in patients with excessive tethering and complex jets without inducing mitral stenosis. Patients with CHF and FMR (3 to 4 /4 ) have a life expectancy of 70% at 1 year after the diagnosis. 10 In this setting, MV repair with a standard undersized ring annuloplasty has been performed with low hospital mortality, symptomatic improvement, and good midterm survival. 11 However, if substantial apical tenting is present or the pattern of the regurgitant jet is complex, then ring annuloplasty alone may not be sufficient. 4 The edge-to-edge technique has been used in patients with FMR and DCM, particularly by the Cleveland Clinic group with a disappointing recurrence rate of moderately severe (3 ) MR at 2 years of 24%. 7 These results, however, were mainly explained by the fact that, in that series, the edge-toedge repair was always used in association with a posterior flexible band, which may not prevent the recurrence of annular dilatation in the setting of advanced DCM. Indeed, the patients requiring reoperation almost invariably presented redilatation of the mitral annulus. In our institution, we decided to use the edge-to-edge technique exclusively in patients with important leaflet tethering with the aim to improve the durability of the undersized annuloplasty and avoid MV replacement. However, the edge-to-edge was always associated with an undersized annuloplasty performed with a complete ring (preferentially rigid or semirigid) and the site of leaflet approximation was literally guided by the TTE/TEE findings. This approach resulted in a 3.7% recurrence rate of 3 to 4 MR at follow-up that was 6-fold lower compared with that registered with the undersized annuloplasty alone (21.7%) despite having, in the edge-to-edge patients, the more-advanced degree of leaflet tethering. Freedom from recurrence of severe MR at 1.5 years was 20% higher in the edge-to-edge group. Even considering all the cases of recurrence of MR 2, the 14.8% rate of our edge-to-edge experience compared favorably with the 34% registered in the ring-only group of our series and with the 29% reported by Tahta et al, 1 using a flexible downsized ring. In the current study, the use of the edge-to-edge technique was identified as the only significant predictor of durability of MV repair. By ensuring leaflet coaptation exactly where the tethering is more pronounced, the edge-to-edge approach could abolish the occurrence of the loitering effect 12 and prevent the recurrence of MR. Moreover, by anchoring the leaflets together, it could exert a kind of reins effect on the LV chamber, counteracting the progression of the LV remodeling, which can lead to recurrence of MR. 13 The serial echocardiographic follow-ups allowed the assessment of LV reverse remodeling after surgery showing that, when volume overload is abolished by a successful repair, a significant decrease of LV dimensions develops early after surgery and remains substantially stable in the following 15 months in both idiopathic and ischemic patients. Finally, for very sick patients, as those included in this series, the opportunity of performing a reconstructive procedure rather than a chordalsparing valve replacement has been questioned. 4,14 We have always been rather concerned by the impact of MV replacement (although performed preserving all the subvalvular apparatus) on LV systolic function over time. If a fairly durable MV repair can be performed, we still believe this would represent the best option for these high-risk patients. Limitations This study has several limitations. The number of patients is relatively small, together with the number of late events. The assignment of the patients to one or another technique was not performed in a randomized fashion. However, it should be considered that only patients with MR secondary to really end-stage DCM (EF 35%; NYHA III-IV) were prospectively included in this series and that the number of events, although relatively small, was enough to show a statistically significant difference between the 2 groups. As far as the

7 I-408 Circulation August 30, 2005 assignment of the patients to one or another technique is concerned, we used criteria that have been reported to be associated with failure of the undersized annuloplasty (coaptation depth 1 cm; complex jets) to select the cases where adding the edge-to-edge technique could have been potentially beneficial. In particular, we used the coaptation depth, which represents the ultimate mechanism of functional MR independent of LV function and shape (sphericity index). 15 Several factors (ischemic or idiopathic etiology of DCM, age, previous AMI, EF, LV dimensions, annuloplasty ring type and number, associate CABG, and type of regurgitant jet) might have influenced the results. Nevertheless, none of them were shown to be significantly correlated with the recurrence of MR. The potential role of concomitant myocardial revascularization on MV function has also to be considered. We cannot exclude that concomitant CABG might have improved the mitral apparatus function by some recruitment of the hibernating myocardium. However, there were no differences between the 2 groups in terms of presence and distribution of hibernating myocardium, number of patients undergoing CABG, and number of grafts and coronary arteries revascularized. Therefore, if any effect on mitral function has been exerted by concomitant CABG, this should have been comparable in the 2 groups. Finally, these data have to be considered as preliminary results, which need to be confirmed by a larger number of patients and a significantly longer follow-up. References 1. Tahta SA, Oury JH, Maxwell JM, Hiro SP, Duran CM. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis. 2002;11: Calafiore AM, Gallina S, Di Mauro M, Gaeta F, Iaco AL, D Allesandro S, Mazzei V, Di Giammarco G. Mitral valve procedure in dilated cardiomyopathy: repair or replacement. Ann Thorac Surg. 2001;71: Hung J, Handschumacher MD, Rudski L, Chow CM, Guerrero JL, Levine RA. Persistence of ischemic mitral regurgitation despite annular ring reduction: mechanistic insights from 3D echocardiography. Circulation. 1999;100:I Miller DC. Ischemic mitral regurgitation redux To repair or to replace? J Thorac Cardiovasc Surg. 2001;122: Umana JP, Salehizadeh BS, DeRose JJ, Nahar T, Lotvin A, Homma S, Oz MC. Bow-tie mitral valve repair: an adjuvant technique for ischemic mitral regurgitation. Ann Thorac Surg. 1998;66: Kinnaird TD, Munt BI, Ignaszewski AP, Abel JG, Thompson CR. Edgeto-edge repair for functional mitral regurgitation: an echocardiographic study of the hemodynamic consequences. J Heart Valve Dis. 2003;12: Bhudia SK, McCarthy PM, Smedira NG, Lam B, Rajeswaran J, Blackstone EH. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg. 2004;77: La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23: Tibayan FA, Rodriguez F, Langer F, Zasio M, Bailey L, Liang D, Daughters GT, Ingels NB, Miller DC. Annular remodeling in chronic ischemic mitral regurgitation: ring selection implications. Ann Thorac Surg. 2003;76: Trichon BH, Felker GM, Shaw LK, Cabell CH, O Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91: Romano MA, Bolling SF. Update on mitral repair in dilated cardiomyopathy. J Card Surg. 2004;19: Glasson JR, Komeda M, Daughters GT, Bolger AF, Karlsson MO, Foppiano LE, Hayase M, Oesterle SN, Ingels NB Jr, Miller DG. Early systolic mitral leaflet loitering during acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 1998;116: Hung J, Papakostas L, Tahta SA, Hardy BG, Bollen BA, Duran CM, Levine RA. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Continued LV remodeling as a moving target. Circulation. 2004;110(suppl II):II85 II Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J, Lytle BW, McCarthy PM. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122: Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Steven F Bolling Professor of Cardiac Surgery University of Michigan

Steven F Bolling Professor of Cardiac Surgery University of Michigan Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan Functional MR Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure,

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

Surgical repair techniques for IMR: future percutaneous options?

Surgical repair techniques for IMR: future percutaneous options? Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Case Report Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Antonio Chiricolo 1*, Leonard Y Lee 2 1 Department of Anesthesiology, Rutgers

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Device Landscape 2010 PERCUTANEOUS TECHNIQUES Percutaneous indirect annuloplasty Percutaneous direct annuloplasty Edge to Edge ( E-Valve ) Non

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

The natural history of the dilated cardiomyopathy

The natural history of the dilated cardiomyopathy ORIGINAL ARTICLES: CARDIOVASCULAR Mitral Valve Procedure in Dilated Cardiomyopathy: Repair or Replacement? Antonio M. Calafiore, MD, Sabina Gallina, MD, Michele Di Mauro, MD, Filoteo Gaeta, MD, Angela

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Valve Analysis and Pathoanatomy: THE MITRAL VALVE : THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery

More information

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Disclosures I have nothing to disclose FMR: a ventricular

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications

More information

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography

More information

A Prospective Study of Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring Annuloplasty

A Prospective Study of Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring Annuloplasty A Prospective Study of Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring Annuloplasty Farideh Roshanali, MD, Mohammad Hossein Mandegar, MD, Mohammad Ali Yousefnia, MD, Hussein Rayatzadeh,

More information

Management of Tricuspid Regurgitation

Management of Tricuspid Regurgitation Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Despite advances in our understanding of the pathophysiology

Despite advances in our understanding of the pathophysiology Suture Relocation of the Posterior Papillary Muscle in Ischemic Mitral Regurgitation Benjamin B. Peeler MD,* and Irving L. Kron MD,*, *Department of Cardiovascular Surgery, University of Virginia, Charlottesville,

More information

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and

More information

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery Techniques for ischemic mitral valve disease: An Update Conflict of Interest Disclosure Grant/ Research Support: NHLBI RO1 HL67025 Consulting Fees/Honoraria: Stanford PI PARTNER Trial, Edwards Lifesciences

More information

Functional mitral regurgitation (MR), which occurs as a

Functional mitral regurgitation (MR), which occurs as a Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation Real-Time Three-Dimensional Echocardiography Study Jun Kwan, MD; Takahiro

More information

MitraClip in the ICCU: Which Patient will Benefit?

MitraClip in the ICCU: Which Patient will Benefit? MitraClip in the ICCU: Which Patient will Benefit? DAVID MEERKIN STRUCTURAL A ND CONGENITAL HEART DISEASE UNIT SHAARE ZEDEK MEDICAL CENTER JERUSALEM Conflict of Interest No relevant disclosures Complex

More information

The icoapsys Repair System for the percutaneous treatment of functional mitral insufficiency

The icoapsys Repair System for the percutaneous treatment of functional mitral insufficiency Percutaneous valve interventions The icoapsys Repair System for the percutaneous treatment of functional mitral insufficiency Wes R. Pedersen 1 *, MD, FACC, FSCAI; Peter Block 2, MD, FACC, FSCAI; Ted Feldman

More information

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Surgery for Acquired Cardiovascular Disease Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD, Joseph A. Dearani, MD,

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

What echo measurements are key prior to MitraClip?

What echo measurements are key prior to MitraClip? APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Risk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects

Risk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Ischaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic

Ischaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic Correspondence to: Professor Bernard Iung, Service de Cardiologie, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France; bernard.iung@ bch.ap-hop-paris.fr Valve

More information

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction Original Article Comparison of outcomes of tricuspid annuloplasty with 3D-rigid versus flexible prosthetic ring for functional tricuspid regurgitation secondary to rheumatic mitral valve disease Haiping

More information

When should we intervene surgically in pediatric patient with MR?

When should we intervene surgically in pediatric patient with MR? When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease Mechanisms of Recurrent Functional Mitral Regurgitation After Mitral Valve Repair in Nonischemic Dilated Cardiomyopathy Importance of Distal Anterior Leaflet Tethering Alex Pui-Wai

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Ischemic mitral regurgitation (IMR) is an insufficiency of

Ischemic mitral regurgitation (IMR) is an insufficiency of Repair Techniques for Ischemic Mitral Regurgitation Damien J. LaPar, MD, MSc, and Irving L. Kron, MD Ischemic mitral regurgitation (IMR) is an insufficiency of the mitral valve (MV) secondary to myocardial

More information

Mitral Valve Repair for 52 Patients with Severe Left Ventricular Dysfunction

Mitral Valve Repair for 52 Patients with Severe Left Ventricular Dysfunction Original Article Mitral Valve Repair for 52 Patients with Severe Left Ventricular Dysfunction Mikiko Murakami, MD, Hiroki Yamaguchi, MD, PhD, Yuji Suda, MD, PhD, Tomohiro Asai, MD, PhD, Michiaki Sueishi,

More information

Clinical outcomes of surgery of mitral valve regurgitation and coronary artery bypass grafting

Clinical outcomes of surgery of mitral valve regurgitation and coronary artery bypass grafting doi:10.1510/icvts.2006.128785 Interactive CardioVascular and Thoracic Surgery 5 (2006) 392 397 Institutional report - Cardiac general Clinical outcomes of surgery of mitral valve regurgitation and coronary

More information

Functional Mitral Regurgitation

Functional Mitral Regurgitation Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function

Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Ashish S. Shah, MD, Steven A. Hannish, MD, Carmelo A. Milano, MD, and Donald D. Glower, MD Department of General and Thoracic

More information

I have financial relationships to disclose Honoraria from: Edwards

I have financial relationships to disclose Honoraria from: Edwards I have financial relationships to disclose Honoraria from: Edwards Mitral Valve Annuloplasty in Ischemic Mitral regurgitation Jean François Avierinos Hôpital Timone Marseille August 28, 2012 Ischemic MR

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

Current status: Percutaneous mitral valve therapy

Current status: Percutaneous mitral valve therapy Current status: Percutaneous mitral valve therapy Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital ESC Stockholm 2010 Disclosures Research Grants Abbott, Edwards Consultant Abbott, Edwards 2 Percutaneous

More information

Quantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography

Quantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography Journal of the American College of Cardiology Vol. 45, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.048

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN Carpentier s principles

More information

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement Prakash P Punjabi FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Consultant Cardiothoracic Surgeon Imperial College Healthcare NHS Trust Hammersmith

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Prognostic Impact of FMR

Prognostic Impact of FMR Secondary Mitral Valve Regurgitation in Heart Failure, Age 60 Years From Medical Therapy to Surgical Repair to Transcatheter Intervention The Interventionalist s View Samin K Sharma, MD, FACC, FSCAI Director

More information

MITRAL REGURGITATION ECHO PARAMETERS TOOL

MITRAL REGURGITATION ECHO PARAMETERS TOOL Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and

More information

Basic principles of Rheumatic mitral valve Repair

Basic principles of Rheumatic mitral valve Repair Basic principles of Rheumatic mitral valve Repair Prof. Gebrine El Khoury, MD DEPARTMENT OF CARDIOVASCULAR AND THORACIC SURGERY ST. LUC HOSPITAL - BRUSSELS, BELGIUM 1 Rheumatic MV disease MV repair confers

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation

More information

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ; CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ; Επιµορφωτικά Σεµινάρια Ειδικευοµένων Καρδιολογίας 7 Απριλίου 2012 M Chrissoheris MD FACC THV Department HYGEIA Hospital Degenerative MR (DMR) Usually refers to an anatomic

More information

Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device

Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device The Scientific World Journal Volume 2013, Article ID 925310, 4 pages http://dx.doi.org/10.1155/2013/925310 Research Article Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular

More information

Isolated Undersized Mitral Annuloplasty for Functional Mitral Regurgitation in Non-Ischemic Dilated Cardiomyopathy

Isolated Undersized Mitral Annuloplasty for Functional Mitral Regurgitation in Non-Ischemic Dilated Cardiomyopathy Circ J 28; 72: 1744 175 Isolated Undersized Mitral Annuloplasty for Functional Mitral Regurgitation in n-ischemic Dilated Cardiomyopathy Reconsideration of the Relationship Between Preoperative Coaptation

More information

Update on Mitral Repair in Dilated Cardiomyopathy

Update on Mitral Repair in Dilated Cardiomyopathy 396 Update on Mitral Repair in Dilated Cardiomyopathy Matthew A. Romano, M.D., and Steven F. Bolling, M.D. University of Michigan, Section of Cardiac Surgery, Ann Arbor, Michigan ABSTRACT Heart failure

More information

Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry

Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry A. Colli, E. Bizzotto, E. Manzan, L. Besola, F. Zucchetta, D.Pittarello,

More information

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

The HRT Mitral Bridge Technology for Functional MR

The HRT Mitral Bridge Technology for Functional MR The HRT Mitral Bridge Technology for Functional MR Carlos E. Ruiz, MD, PhD, FACC, FESC, MSCAI Professor of Cardiology in Pediatrics and Medicine Director of Structural and Congenital Heart Disease Program

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Tricuspid valve surgery in patients with a systemic right ventricle

Tricuspid valve surgery in patients with a systemic right ventricle Tricuspid valve surgery in patients with a systemic right ventricle Roderick Scherptong, Hubert Vliegen, Michiel Winter, Barbara Mulder, Ernst van der Wall, Dave Koolbergen, Mark Hazekamp Eduard Holman,

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

Myxomatous degeneration of the mitral valve is the

Myxomatous degeneration of the mitral valve is the CARDIOVASCULAR Midterm Results of the Edge-to-Edge Technique for Complex Mitral Valve Repair Derek R. Brinster, MD, Daniel Unic, MD, Michael N. D Ambra, MD, Nadia Nathan, MD, and Lawrence H. Cohn, MD Division

More information

Percutaneous mitral annuloplasty. Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy

Percutaneous mitral annuloplasty. Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy Percutaneous mitral annuloplasty Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy Disclosure Consultant for Abbott, Medtronic, St Jude, Edwards, ValtechCardio Founder of 4Tech Surgical techniques

More information

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;

More information

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,

More information

Case # 1. Page: 8. DUKE: Adams

Case # 1. Page: 8. DUKE: Adams Case # 1 Page: 8 1. The cardiac output in this patient is reduced because of: O a) tamponade physiology O b) restrictive physiology O c) coronary artery disease O d) left bundle branch block Page: 8 1.

More information

Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty

Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty Original Article Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty Keiichiro Kondo, MD, Yoshihide Sawada, MD, and Shinjiro Sasaki, MD, PhD It is necessary

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1

More information

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui

More information

Although most surgeons would agree that severe mitral

Although most surgeons would agree that severe mitral Does Coronary Artery Bypass Grafting Alone Correct Moderate Ischemic Mitral Regurgitation? Lishan Aklog, MD; Farzan Filsoufi, MD; Kathryn Q. Flores, MD; Raymond H. Chen, MD; Lawrence H. Cohn, MD; Nadia

More information

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Mitral valve surgery has changed considerably in the past decades and is now indicated

Mitral valve surgery has changed considerably in the past decades and is now indicated Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation

More information

Double row of overlapping sutures for downsizing annuloplasty decreases the risk of residual regurgitation in ischaemic mitral valve repair

Double row of overlapping sutures for downsizing annuloplasty decreases the risk of residual regurgitation in ischaemic mitral valve repair European Journal of Cardio-Thoracic Surgery 49 (2016) 1182 1187 doi:10.1093/ejcts/ezv291 Advance Access publication 8 September 2015 ORIGINAL ARTICLE Cite this article as: Nappi F, Spadaccio C, Chello

More information

Degenerative mitral valve disease is the leading cause of

Degenerative mitral valve disease is the leading cause of Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease Willem Flameng, MD, PhD; Paul Herijgers, MD, PhD; Kris Bogaerts, MSc Background Durability assessment of

More information

ΓΙΩΡΓΟΣ ΜΑΚΑΒΟΣ, MD, PhD ΚΑΡΔΙΟΛΟΓΟΣ, ΕΠΙΜΕΛΗΤΗΣ Β Γ ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Γ.Ν.Ν.Θ.Α. ΣΩΤΗΡΙΑ

ΓΙΩΡΓΟΣ ΜΑΚΑΒΟΣ, MD, PhD ΚΑΡΔΙΟΛΟΓΟΣ, ΕΠΙΜΕΛΗΤΗΣ Β Γ ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Γ.Ν.Ν.Θ.Α. ΣΩΤΗΡΙΑ ΓΙΩΡΓΟΣ ΜΑΚΑΒΟΣ, MD, PhD ΚΑΡΔΙΟΛΟΓΟΣ, ΕΠΙΜΕΛΗΤΗΣ Β Γ ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Γ.Ν.Ν.Θ.Α. ΣΩΤΗΡΙΑ Causes of TR Primary-Organic Secondary-Functional Rheumatic LV,valvular dysfunction I.Endocarditis

More information

Surgery for Valvular Heart Disease. RING STRING Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering

Surgery for Valvular Heart Disease. RING STRING Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering Surgery for Valvular Heart Disease RING STRING Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering Frank Langer, MD; Takashi Kunihara, MD, PhD; Klaus Hell; Rene

More information